论文信息 - Masitinib as an adjunct therapy for mild-to-moderate Alzheimer's disease: a randomised, placebo-controlled phase 2 trial - 字舞流文

Masitinib as an adjunct therapy for mild-to-moderate Alzheimer's disease: a randomised, placebo-controlled phase 2 trial

L. Hugonot-Diener | J. Kinet | F. Piette | P. Dubreuil | O. Hermine | J. Belmin | M. Verny | A. Moussy | S. Pariel | Nicolas Schmidt | Hélène Vincent | Caroline Marquis | Jean Mely | L. Hugonot‐Diener